Annual report [Section 13 and 15(d), not S-K Item 405]

STOCKHOLDERS' EQUITY (Tables)

v3.25.0.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2024
STOCKHOLDERS' EQUITY  
Schedule of restricted stock unit activity

Weighted Average

    

Amount

    

Grant Date Fair Value

    

Outstanding at December 31, 2023

532,399

$

14.82

Granted

1,148,201

 

7.07

Forfeited

(78,986)

 

14.66

Vested

(221,337)

14.90

Outstanding December 31, 2024

1,380,277

$

8.38

Weighted Average

    

Amount

    

Grant Date Fair Value

    

Outstanding at December 31, 2022

1,374,383

$

10.72

Granted

390,887

 

14.96

Forfeited

(40,516)

14.87

Vested (1)

(1,192,355)

11.14

Outstanding December 31, 2023

532,399

$

14.82

(1) Includes 1,063,333 performance units that vested at the 200% vesting target effective December 22, 2023, for which 526,888 shares of common stock underlying vested RSUs were withheld to cover tax obligations. The shares withheld are again available for issuance under the plan.
Schedule of options granted

Grant Date

Grant Date

June 7, 2024

July 1, 2024

Risk-free interest rate

4.42%

4.44%

Expected volatility of common stock

50.04%

50.03%

Dividend yield

-

-

Expected option term in years

6.0

6.0

Grant-date fair value (per share)

$ 3.73

$ 3.46

Schedule of stock options activity

Amount

Weighted Average Exercise Price per Share

Weighted Average Remaining Contractual Life (Years)

Aggregate Intrinsic Value (1)

Outstanding at December 31, 2023

-

$

-

-

-

Granted

646,301

7.02

9.44

-

Forfeited

-

-

-

-

Vested

-

-

-

-

Outstanding December 31, 2024

646,301

$

7.02

9.44

Exercisable

-

$

-

-

-

(1) Total shares valued at the market price of the underlying stock as of December 31, 2024 less the exercise price.